Literature DB >> 7590071

P2 purinergic receptors for diadenosine polyphosphates in the nervous system.

J Pintor1, M T Miras-Portugal.   

Abstract

1. The actions of diadenosine polyphosphates, diadenosine tetraphosphate (Ap4A), diadenosine pentaphosphate (Ap5A) and diadenosine hexaphosphate (Ap6A) in the nervous system have been reviewed. 2. In the peripheral nervous system, diadenosine polyphosphates bind to P2-purinergic receptors such as the P2Y in chromaffin cells and Torpedo synaptosomes, P2X in vas deferens and urinary bladder and also Torpedo synaptosomes and P2U in endothelial chromaffin cells. 3. In the central nervous system ApnA compounds can act through P2X-purinoceptors opening cation channels in nodose ganglion neurones. Diadenosine polyphosphates bind to a P2d-purinergic receptor in rat brain synaptic terminals and hippocampus, linked to protein kinase C (PKC) activation. 4. P4-purinoceptors are specific receptors for diadenosine polyphosphates, coupled to the Ca2+ influx, in the central synapses. This purinoceptor is not activated by ATP and synthetic analogs. The P4-purinoceptor could act as a positive modulator of the synaptic transmission, giving even more importance to diadenosine polyphosphates as neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590071     DOI: 10.1016/0306-3623(94)00182-m

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  11 in total

1.  Diadenosine polyphosphates induce intracellular Ca2+ mobilization in human neutrophils via a pertussis toxin sensitive G-protein.

Authors:  L Gasmi; A G McLennan; S W Edwards
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

2.  Diadenosine tetraphosphate contributes to carbachol-induced tear secretion.

Authors:  Begoña Fonseca; Alejandro Martínez-Águila; Miguel Díaz-Hernández; Jesús Pintor
Journal:  Purinergic Signal       Date:  2014-11-15       Impact factor: 3.765

3.  Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1-adenosine receptors.

Authors:  U Vahlensieck; P Bokník; J Knapp; B Linck; F U Müller; J Neumann; S Herzig; H Schlüter; W Zidek; M C Deng; H H Scheld; W Schmitz
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors.

Authors:  J Pintor; B F King; M T Miras-Portugal; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  Modulation of the dinucleotide receptor present in rat midbrain synaptosomes by adenosine and ATP.

Authors:  M Díaz-Hernández; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Structure-activity relationships of diadenosine polyphosphates (Ap(n)As), adenosine polyphospho guanosines (Ap(n)Gs) and guanosine polyphospho guanosines (Gp(n)Gs) at P2 receptors in the rat mesenteric arterial bed.

Authors:  V Ralevic; J Jankowski; H Schlüter
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

7.  Characterization of the binding of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) to rat liver cell membranes.

Authors:  M Edgecombe; A G McLennan; M J Fisher
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

8.  Diadenosine polyphosphates evoke Ca2+ transients in guinea-pig brain via receptors distinct from those for ATP.

Authors:  J Pintor; J A Puche; J Gualix; C H Hoyle; M T Miras-Portugal
Journal:  J Physiol       Date:  1997-10-15       Impact factor: 5.182

9.  A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes.

Authors:  J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

10.  Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.

Authors:  E R Lazarowski; W C Watt; M J Stutts; R C Boucher; T K Harden
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.